0

sTRAIL Receptor-2 (DR5) human

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR4248886
Descriptionrecombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Assay≥98% (HPLC); ≥98% (SDS-PAGE)
Colorwhite
Formlyophilized
Impurity Content<0.1 EU/μg endotoxin, tested
Size50μG
Storage Conditions−20°C
1

Delivery of sTRAIL Variants by MSCs in Combination With Cytotoxic Drug Treatment Leads to p53-independent Enhanced Antitumor Effects

R Yu, L Deedigan, S M Albarenque, A Mohr, R M Zwacka

Cell Death Dis. 2013 Feb 21;4(2):e503.

PMID: 23429289

1

DR4 Specific TRAIL Variants Are More Efficacious Than Wild-Type TRAIL in Pancreatic Cancer

Rui Yu, Stella Maris Albarenque, Robbert H Cool, Wim J Quax, Andrea Mohr, Ralf M Zwacka

Cancer Biol Ther. 2014;15(12):1658-66.

PMID: 25482930

1

Effect of a Novel Fully Human Monovalent Antigen-Binding Fragment on the Survival of Cancer Cell Lines

Yong Soon Kwon, You-Ri Lee, Yong-Sung Kim, Hyun-Wook Lee, Young-Ju Jang

Oncol Rep. 2007 Aug;18(2):513-7.

PMID: 17611678

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode